Ortho-McNeil Pharmaceutical, in conjunction with the R.W. Johnson Pharmaceutical Research Institute uses radio labeled compounds for pharmaceutical research and development at their Spring House, PA facility. This manufacturing process yields a waste solution containing both radioactive material and an organic compound, which comprises a "mixed waste" under RCRA. The mixed waste is stored on site in accordance with a PA and EPA enforcement discretion policy for such wastes. Ortho-McNeil proposes to obtain superior environmental benefits through the use of an on-site bench-top catalytic oxidation process to treat the mixed waste, which would represent a more efficient, environmentally safe process as compared with current waste management and disposal practices.